Scott MG - Search Results

1

Sublingual captopril--a pharmacokinetic and pharmacodynamic evaluation.

al-Furaih TA, McElnay JC, Elborn JS, Rusk R, Scott MG, McMahon J, Nicholls DP. al-Furaih TA, et al. Among authors: scott mg. Eur J Clin Pharmacol. 1991;40(4):393-8. doi: 10.1007/BF00265850. Eur J Clin Pharmacol. 1991. PMID: 2050174 Clinical Trial.

2

A pharmacokinetic and pharmacodynamic comparison of plain and enteric-coated prednisolone tablets.

Adair CG, McCallion O, McElnay JC, Scott MG, Hamilton BA, McCann JP, Stanford CF, Nicholls DP. Adair CG, et al. Among authors: scott mg. Br J Clin Pharmacol. 1992 May;33(5):495-9. doi: 10.1111/j.1365-2125.1992.tb04076.x. Br J Clin Pharmacol. 1992. PMID: 1524961 Free PMC article. Clinical Trial.

3

Prediction of netilmicin disposition in neonates.

Darwish M, Batayneh M, Jenkins J, Scott M, Collier PS, McElnay JC. Darwish M, et al. Biopharm Drug Dispos. 1992 Mar;13(2):105-18. doi: 10.1002/bdd.2510130205. Biopharm Drug Dispos. 1992. PMID: 1550906

4

Audiovisual demonstration for patient counselling in the use of pressurised aerosol bronchodilator inhalers.

McElnay JC, Scott MG, Armstrong AP, Stanford CF. McElnay JC, et al. Among authors: scott mg. J Clin Pharm Ther. 1989 Apr;14(2):135-44. doi: 10.1111/j.1365-2710.1989.tb00232.x. J Clin Pharm Ther. 1989. PMID: 2470768 Clinical Trial.

5

Haemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin.

Scott MG, Deering AH, McMahon MT, Harron DW, Shanks RG. Scott MG, et al. Eur J Clin Pharmacol. 1989;37(1):53-8. doi: 10.1007/BF00609425. Eur J Clin Pharmacol. 1989. PMID: 2591463 Clinical Trial.

6

Chlordiazepoxide metabolite accumulation in liver disease.

Barton K, Auld PW, Scott MG, Nicholls DP. Barton K, et al. Among authors: scott mg. Med Toxicol Adverse Drug Exp. 1989 Jan-Feb;4(1):73-6. doi: 10.1007/BF03259904. Med Toxicol Adverse Drug Exp. 1989. PMID: 2710011

7

Audit of antibiotic usage in medium-sized general hospital over an 11-year period. The impact of antibiotic policies.

McElnay JC, Scott MG, Sidara JY, Kearney P. McElnay JC, et al. Among authors: scott mg. Pharm World Sci. 1995 Nov 24;17(6):207-13. doi: 10.1007/BF01870613. Pharm World Sci. 1995. PMID: 8597778

8

The effect of pH on the buccal and sublingual absorption of captopril.

McElnay JC, al-Furaih TA, Hughes CM, Scott MG, Elborn JS, Nicholls DP. McElnay JC, et al. Among authors: scott mg. Eur J Clin Pharmacol. 1995;48(5):373-9. doi: 10.1007/BF00194953. Eur J Clin Pharmacol. 1995. PMID: 8641325 Clinical Trial.

9

A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure.

McElnay JC, al-Furaih TA, Hughes CM, Scott MG, Nicholls DP. McElnay JC, et al. Among authors: scott mg. Eur J Clin Pharmacol. 1996;49(6):471-6. doi: 10.1007/BF00195933. Eur J Clin Pharmacol. 1996. PMID: 8706772 Clinical Trial.

10

Using bar-code technology to capture clinical intervention data in a hospital with a stand-alone pharmacy computer system.

Scott MG, McElnay JC, Burnett KM. Scott MG, et al. Am J Health Syst Pharm. 1996 Mar 15;53(6):651-4. doi: 10.1093/ajhp/53.6.651. Am J Health Syst Pharm. 1996. PMID: 8800970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters